These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8038709)

  • 41. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist.
    Butcher C; Steinkasserer A; Tejura S; Lennard AC
    J Immunol; 1994 Jul; 153(2):701-11. PubMed ID: 8021506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.
    Giri JG; Wells J; Dower SK; McCall CE; Guzman RN; Slack J; Bird TA; Shanebeck K; Grabstein KH; Sims JE
    J Immunol; 1994 Dec; 153(12):5802-9. PubMed ID: 7989776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
    Arend WP
    J Clin Invest; 1991 Nov; 88(5):1445-51. PubMed ID: 1834696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes.
    Conti P; Panara MR; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Agents Actions; 1992; Spec No():C93-5. PubMed ID: 1332453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
    Dinarello CA
    Int Rev Immunol; 1998; 16(5-6):457-99. PubMed ID: 9646173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of interleukin-1 receptor antagonist protein in malignant lymphomas. An immunohistochemical study.
    Shin SS; Traweek ST; Ulich TR
    Arch Pathol Lab Med; 1995 Mar; 119(3):247-51. PubMed ID: 7887778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interleukin-1 (IL-1), IL-1 receptor, IL-1 receptor antagonist (IL-1ra)].
    Hayashi H; Onozaki K
    Nihon Rinsho; 1999 Nov; 57 Suppl():769-74. PubMed ID: 10635966
    [No Abstract]   [Full Text] [Related]  

  • 50. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
    Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
    J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA; Thompson RC
    Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-1 receptor antagonist.
    Arend WP
    Adv Immunol; 1993; 54():167-227. PubMed ID: 8379462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
    Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA
    Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor.
    Loscher CE; Mills KH; Lynch MA
    J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
    Hung GL; Galea-Lauri J; Mueller GM; Georgescu HI; Larkin LA; Suchanek MK; Tindal MH; Robbins PD; Evans CH
    Gene Ther; 1994 Jan; 1(1):64-9. PubMed ID: 7584062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-1 receptor antagonist: role in biology.
    Arend WP; Malyak M; Guthridge CJ; Gabay C
    Annu Rev Immunol; 1998; 16():27-55. PubMed ID: 9597123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha.
    Chole RA; Tinling SP; Faddis BT
    Calcif Tissue Int; 1994 Jul; 55(1):12-5. PubMed ID: 7922783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo.
    Qian L; Xiang D; Zhang J; Zhu S; Gao J; Wang X; Gao J; Zhang Y; Shen J; Yu Y; Han W; Wu M
    Biomed Pharmacother; 2013 Mar; 67(2):108-15. PubMed ID: 23433850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-1ra: properties and uses of an interleukin-1 receptor antagonist.
    Thompson RC; Dripps DJ; Eisenberg SP
    Agents Actions Suppl; 1991; 35():41-9. PubMed ID: 1838233
    [No Abstract]   [Full Text] [Related]  

  • 60. Physiologic role of interleukin-1 receptor antagonist.
    Arend WP; Gabay C
    Arthritis Res; 2000; 2(4):245-8. PubMed ID: 11094434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.